INVEGA® (Paliperidone ER) Approved As First Antipsychotic Treatment For Schizoaffective Disorder In The EU
Links shared publicly online about this topic.
- 598total visits
INVEGA® (Paliperidone ER) Approved As First Antipsychotic Treatment For Schizoaffective Disorder In The EU
View full resource at medicalnewstoday.com
Tags: Bipolar Disorder, Depression, Schizophrenia, Schizoaffective Disorder, Psychotic Disorder, Disease and Condition
Most Recently Shared on January 7, 2011 at 2:05 pm By:
INVEGA® (Paliperidone ER) Approved As First Antipsychotic Treatment For Schizoaffective Disorder In The EU http://mnt.to/3PJm
Also Shared By:
INVEGA (Paliperidone) drug information from MPR
empr.com — “INVEGA (Paliperidone) drug information for Schizoaffective disorder, Schizophrenia from MPR including side effects, drug interactions, dosing, contraindications and warnings/precautions.” View full resource at empr.com
Most Recently Shared on June 9, 2011 at 4:45 am By:
MPR News: INVEGA: Indications: added schizophrenia in adolescents. http://bit.ly/AMzNg
Invega satisfaction and usage data | Monitoring more than 390 patients | Drug safety information | MediGuard
mediguard.org — “Invega satisfaction and usage data | Monitoring more than 390 patients | Drug safety information | MediGuard” View full resource at mediguard.org
Most Recently Shared on May 12, 2011 at 12:17 pm By:
More than 52% of #invega users are aged 45-60 ... http://tinyurl.com/4oh6oqb
Invega Approved as Treatment for Schizophrenia in Teens | Psych Central News
psychcentral.com — “A new drug has been approved for a rare population --teens with schizophrenia. The illness is typically diagnosed first in young adulthood, usually the early” View full resource at psychcentral.com
Most Recently Shared on April 13, 2011 at 6:41 pm By:
News: Invega Approved as Treatment for Schizophrenia in Teens http://bit.ly/dMYdtG
INVEGA(R) Approved As Treatment For Schizophrenia In Adolescents
medicalnewstoday.com — “The U.S. Food and Drug Administration (FDA) on April 6 approved INVEGA® (paliperidone) extended-release tablets for the treatment of schizophrenia in adolescents 12 to 17 years of age. The ef” View full resource at medicalnewstoday.com
Most Recently Shared on April 12, 2011 at 10:05 am By:
INVEGA(R) Approved As Treatment For Schizophrenia In Adolescents http://mnt.to/3TvT #schizophrenia
Invega Approved as Treatment for Schizophrenia in Adolescents
drugs.com — “Invega (paliperidone) is used to treat schizophrenia and schizoaffective disorder. Includes Invega side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on April 12, 2011 at 12:14 am By:
Invega Approved as Treatment for Schizophrenia in Adolescents: TITUSVILLE, N.J., April 11, 2011 /PRNewswir... http://bit.ly/e10uNI #drug
Invega Gains Indication for Schizophrenia in Adolescents - ONA
oncologynurseadvisor.com — “The FDA has approved Invega (paliperidone extended-release tablets; Janssen) for the treatment of schizophrenia in adolescents 12--17 years of age.” View full resource at oncologynurseadvisor.com
Most Recently Shared on April 11, 2011 at 2:52 pm By:
Invega Gains Indication for Schizophrenia in Adolescents http://goo.gl/fb/9UJfs
Invega Gains Indication for Schizophrenia in Adolescents - MPR
empr.com — “The FDA has approved Invega (paliperidone extended-release tablets; Janssen) for the treatment of schizophrenia in adolescents 12--17 years of age.” View full resource at empr.com
Most Recently Shared on April 11, 2011 at 2:51 pm By:
MPR News: Invega Gains Indication for Schizophrenia in Adolescents: The FDA has approved Invega (paliperidone ex... http://bit.ly/gIMbNx
INVEGA® Approved as Treatment for Schizophrenia in Adolescents - Press Release - Digital Journal
digitaljournal.com — “Digital Journal is a digital media news network with thousands of Digital Journalists in 200 countries around the world. Join us!” View full resource at digitaljournal.com
Most Recently Shared on April 11, 2011 at 12:18 pm By:
INVEGA® Approved as Treatment for Schizophrenia in Adolescents http://bit.ly/f9DCQB #psychosis #schizo
Licence changes and product updates news | MIMS online
mims.co.uk — “Medical drug news from MIMS online.” View full resource at mims.co.uk
Most Recently Shared on April 4, 2011 at 8:57 am By:
Episenta (valproate), Invega (paliperidone) and Cozaar (losartan) have been approved for additional indications: http://bit.ly/gR8IXo
J&J Scraps Antipsychotic Study - WSJ.com
online.wsj.com — “J&J has scrapped plans for a clinical trial comparing its injectable antipsychotic Invega Sustenna with various oral treatments, citing a reconsideration of priorities.” View full resource at online.wsj.com
Most Recently Shared on March 28, 2011 at 5:23 pm By:
J&J recalls 70,000 Invega syringes | Reuters
reuters.com — “CHICAGO (Reuters) - Johnson & Johnson said it has recalled 70,000 syringes filled with the antipsychotic drug Invega because of cracks in the syringes.A company spokesman said the issue, discovered” View full resource at reuters.com
Most Recently Shared on February 16, 2011 at 4:22 pm By:
J&J recalls 70,000 Invega syringes - QualityPoint Technologies
qualitypointtech.net — “CHICAGO (Reuters) - Johnson & Johnson said it has recalled 70,000 syringes filled with the antipsychotic drug Invega because of cracks in the syringes. (Source: Reuters: Health)” View full resource at qualitypointtech.net
Most Recently Shared on February 16, 2011 at 3:35 pm By:
J&J recalls 70,000 Invega syringes: CHICAGO (Reuters) - Johnson & Johnson said it has recalled 70,000 syringes... http://bit.ly/gJaFfb
J&J recalls 70,000 Invega syringes | Reuters
reuters.com — “CHICAGO (Reuters) - Johnson & Johnson said it has recalled 70,000 syringes filled with the antipsychotic drug Invega because of cracks in the syringes.A company spokesman said the issue, discovered” View full resource at reuters.com
Most Recently Shared on February 16, 2011 at 3:27 pm By:
Microsoft Word - Invega Sustenna Recall Letter for FDA Review Final Cleared by FDA Revised Internal at 632 pm_edit.doc
janssencns.com — “Microsoft Word - Invega Sustenna Recall Letter for FDA Review Final Cleared by FDA Revised Internal at 632 pm_edit.doc” View full resource at janssencns.com
Most Recently Shared on February 15, 2011 at 7:20 pm By:
Janssen® Connect™ Launches In California | Pharmaceutical Processing
pharmpro.com — “Titusville, NJ (January 31, 2011) Janssen& reg; , Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., announced today the launch in California of Janssen& reg; Connect" , a new service for psychiatrists and other healthcare professionals and their patients who have been prescribed a Janssen& reg; long-acting injectable atypical antipsychotic medicine. These medicines are INVEGA& reg; SUSTENNA& reg; (paliperidone palmitate), for the treatment of schizophrenia, and RISPERDAL& reg; CONSTA&” View full resource at pharmpro.com
Most Recently Shared on February 2, 2011 at 1:45 am By:
Janssen® Connect™ Launches In California http://bit.ly/hFNI1z #bipolar
Advertisement



MNT Depression News
@mnt_depression
INVEGA® (Paliperidone ER) Approved As First Antipsychotic Treatment For Schizoaffective Disorder In The EU http://mnt.to/3PJm
1 year ago...